The meta-analysis revealed a pooled sensitivity of 0.80 (95% CI: 0.71-0.87) and a specificity of 0.92 (95% CI: 0.85-0.96) for GDF-15 in distinguishing lung cancer patients from healthy individuals. This evidence concerns the gene GDF15 and lung cancer.